fentanyl has been researched along with Stomatitis in 10 studies
Fentanyl: A potent narcotic analgesic, abuse of which leads to habituation or addiction. It is primarily a mu-opioid agonist. Fentanyl is also used as an adjunct to general anesthetics, and as an anesthetic for induction and maintenance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1078)
fentanyl : A monocarboxylic acid amide resulting from the formal condensation of the aryl amino group of N-phenyl-1-(2-phenylethyl)piperidin-4-amine with propanoic acid.
Stomatitis: INFLAMMATION of the soft tissues of the MOUTH, such as MUCOSA; PALATE; GINGIVA; and LIP.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Transdermal fentanyl is an effective, convenient, and well-tolerated treatment for mucositis pain caused by chemoradiotherapy, which can improve ESCC patients' quality of life." | 9.20 | Efficacy and safety of transdermal fentanyl for the treatment of oral mucositis pain caused by chemoradiotherapy in patients with esophageal squamous cell carcinoma. ( Xing, SZ; Zhang, Y, 2015) |
| "We investigated the efficacy and safety of transdermal fentanyl for severe mucositis pain caused by chemotherapy." | 9.13 | Efficacy and safety of transdermal fentanyl for treatment of oral mucositis pain caused by chemotherapy. ( Cai, Q; Guo, Y; Huang, H; Li, Y; Lin, X; Sun, X; Xia, Z, 2008) |
| "This study evaluated the efficacy, safety, and quality of life (QoL) measure of transdermal fentanyl (TDF) for moderate-to-severe pain due to oral mucositis caused by chemoradiotherapy in patients with advanced nasopharyngeal carcinoma (NPC)." | 7.80 | Transdermal fentanyl for pain due to chemoradiotherapy-induced oral mucositis in nasopharyngeal cancer patients: evaluating efficacy, safety, and improvement in quality of life. ( Feng, HX; Guo, SP; He, ZY; Li, FY; Sun, JY; Wu, SG; Wu, YJ; Zhou, J, 2014) |
| "The current study was performed to evaluate the effectiveness and safety of transdermal therapeutic system (TTS) fentanyl in the management of acute pain due to oral mucositis in patients receiving stem cell transplantation." | 7.73 | Effectiveness of transdermal fentanyl patch for treatment of acute pain due to oral mucositis in patients receiving stem cell transplantation. ( Bae, NY; Baek, JH; Chae, YS; Kim, DH; Kim, JG; Kim, SY; Lee, KB; Sohn, SK, 2005) |
| "Fentanyl is a synthetic opioid that can be delivered through a transdermal therapeutic system (TTS)." | 6.71 | Transdermal fentanyl in HSCT patients: an open trial using transdermal fentanyl for the treatment of oral mucositis pain. ( Carrassi, A; Deliliers, GL; Demarosi, F; Lodi, G; Sardella, A; Soligo, D; Volpe, AD, 2004) |
| "Transdermal fentanyl is an effective, convenient, and well-tolerated treatment for mucositis pain caused by chemoradiotherapy, which can improve ESCC patients' quality of life." | 5.20 | Efficacy and safety of transdermal fentanyl for the treatment of oral mucositis pain caused by chemoradiotherapy in patients with esophageal squamous cell carcinoma. ( Xing, SZ; Zhang, Y, 2015) |
| "We investigated the efficacy and safety of transdermal fentanyl for severe mucositis pain caused by chemotherapy." | 5.13 | Efficacy and safety of transdermal fentanyl for treatment of oral mucositis pain caused by chemotherapy. ( Cai, Q; Guo, Y; Huang, H; Li, Y; Lin, X; Sun, X; Xia, Z, 2008) |
| " This is the first study to investigate the absorption profile of fentanyl buccal tablet (FBT) - an effervescent formulation of fentanyl indicated for the management of breakthrough pain in opioid-tolerant cancer patients - in patients with or without oral mucositis." | 5.12 | Absorption of fentanyl from fentanyl buccal tablet in cancer patients with or without oral mucositis: a pilot study. ( Darwish, M; Jiang, JG; Kirby, M; Robertson, P; Tracewell, W, 2007) |
| "This study evaluated the efficacy, safety, and quality of life (QoL) measure of transdermal fentanyl (TDF) for moderate-to-severe pain due to oral mucositis caused by chemoradiotherapy in patients with advanced nasopharyngeal carcinoma (NPC)." | 3.80 | Transdermal fentanyl for pain due to chemoradiotherapy-induced oral mucositis in nasopharyngeal cancer patients: evaluating efficacy, safety, and improvement in quality of life. ( Feng, HX; Guo, SP; He, ZY; Li, FY; Sun, JY; Wu, SG; Wu, YJ; Zhou, J, 2014) |
| "The current study was performed to evaluate the effectiveness and safety of transdermal therapeutic system (TTS) fentanyl in the management of acute pain due to oral mucositis in patients receiving stem cell transplantation." | 3.73 | Effectiveness of transdermal fentanyl patch for treatment of acute pain due to oral mucositis in patients receiving stem cell transplantation. ( Bae, NY; Baek, JH; Chae, YS; Kim, DH; Kim, JG; Kim, SY; Lee, KB; Sohn, SK, 2005) |
| "Fentanyl is a synthetic opioid that can be delivered through a transdermal therapeutic system (TTS)." | 2.71 | Transdermal fentanyl in HSCT patients: an open trial using transdermal fentanyl for the treatment of oral mucositis pain. ( Carrassi, A; Deliliers, GL; Demarosi, F; Lodi, G; Sardella, A; Soligo, D; Volpe, AD, 2004) |
| " TIRF use was mainly related to background opioid dosage and the patient's self-sufficiency in taking medication." | 1.48 | Breakthrough cancer pain tailored treatment: which factors influence the medication choice? An observational, prospective and cross-sectional study in patients with terminal cancer. ( Calvieri, A; Casale, G; Dardeli, A; Eusepi, G; Giannarelli, D; Magnani, C; Mastroianni, C; Restuccia, MR, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Magnani, C | 1 |
| Giannarelli, D | 1 |
| Calvieri, A | 1 |
| Dardeli, A | 1 |
| Eusepi, G | 1 |
| Restuccia, MR | 1 |
| Mastroianni, C | 1 |
| Casale, G | 1 |
| Mercadante, S | 1 |
| Masedu, F | 1 |
| Valenti, M | 1 |
| Aielli, F | 1 |
| Guo, SP | 1 |
| Wu, SG | 1 |
| Zhou, J | 1 |
| Feng, HX | 1 |
| Li, FY | 1 |
| Wu, YJ | 1 |
| Sun, JY | 1 |
| He, ZY | 1 |
| Bossi, P | 1 |
| Locati, L | 1 |
| Bergamini, C | 1 |
| Mirabile, A | 1 |
| Granata, R | 1 |
| Imbimbo, M | 1 |
| Resteghini, C | 1 |
| Licitra, L | 1 |
| Xing, SZ | 1 |
| Zhang, Y | 1 |
| Cai, Q | 1 |
| Huang, H | 1 |
| Sun, X | 1 |
| Xia, Z | 1 |
| Li, Y | 1 |
| Lin, X | 1 |
| Guo, Y | 1 |
| Shaiova, L | 1 |
| Lapin, J | 1 |
| Manco, LS | 1 |
| Shasha, D | 1 |
| Hu, K | 1 |
| Harrison, L | 1 |
| Portenoy, RK | 1 |
| Demarosi, F | 1 |
| Lodi, G | 1 |
| Soligo, D | 1 |
| Sardella, A | 1 |
| Volpe, AD | 1 |
| Carrassi, A | 1 |
| Deliliers, GL | 1 |
| Kim, JG | 1 |
| Sohn, SK | 1 |
| Kim, DH | 1 |
| Baek, JH | 1 |
| Chae, YS | 1 |
| Bae, NY | 1 |
| Kim, SY | 1 |
| Lee, KB | 1 |
| Darwish, M | 1 |
| Kirby, M | 1 |
| Robertson, P | 1 |
| Tracewell, W | 1 |
| Jiang, JG | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Comparison of Controlled-release Oxycodone to Control Chemoradiotherapy-induced Moderate or Severe Oral Mucositis Pain in Nasopharyngeal Carcinoma Patients[NCT03045484] | 70 participants (Anticipated) | Interventional | 2016-05-31 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
6 trials available for fentanyl and Stomatitis
| Article | Year |
|---|---|
Breakthrough pain in patients with head & neck cancer. A secondary analysis of IOPS MS study.
Topics: Administration, Intranasal; Adolescent; Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Breakthr | 2019 |
Efficacy and safety of transdermal fentanyl for the treatment of oral mucositis pain caused by chemoradiotherapy in patients with esophageal squamous cell carcinoma.
Topics: Administration, Cutaneous; Adult; Aged; Analgesics, Opioid; Carcinoma, Squamous Cell; Chemoradiother | 2015 |
Efficacy and safety of transdermal fentanyl for treatment of oral mucositis pain caused by chemotherapy.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Analgesics, Opioid; Antineoplastic Combined Chem | 2008 |
Tolerability and effects of two formulations of oral transmucosal fentanyl citrate (OTFC; ACTIQ) in patients with radiation-induced oral mucositis.
Topics: Administration, Oral; Adult; Aged; Analgesics, Opioid; Chemistry, Pharmaceutical; Cross-Over Studies | 2004 |
Transdermal fentanyl in HSCT patients: an open trial using transdermal fentanyl for the treatment of oral mucositis pain.
Topics: Administration, Cutaneous; Adult; Aged; Female; Fentanyl; Hematologic Neoplasms; Hematopoietic Stem | 2004 |
Absorption of fentanyl from fentanyl buccal tablet in cancer patients with or without oral mucositis: a pilot study.
Topics: Absorption; Administration, Buccal; Adult; Aged; Analgesics, Opioid; Antineoplastic Agents; Female; | 2007 |
4 other studies available for fentanyl and Stomatitis
| Article | Year |
|---|---|
Breakthrough cancer pain tailored treatment: which factors influence the medication choice? An observational, prospective and cross-sectional study in patients with terminal cancer.
Topics: Administration, Buccal; Administration, Intranasal; Aged; Aged, 80 and over; Analgesics, Opioid; Bre | 2018 |
Transdermal fentanyl for pain due to chemoradiotherapy-induced oral mucositis in nasopharyngeal cancer patients: evaluating efficacy, safety, and improvement in quality of life.
Topics: Administration, Cutaneous; Adult; Carcinoma; Chemoradiotherapy; Female; Fentanyl; Humans; Male; Midd | 2014 |
Fentanyl pectin nasal spray as treatment for incident predictable breakthrough pain (BTP) in oral mucositis induced by chemoradiotherapy in head and neck cancer.
Topics: Administration, Inhalation; Adult; Aged; Analgesics, Opioid; Breakthrough Pain; Combined Modality Th | 2014 |
Effectiveness of transdermal fentanyl patch for treatment of acute pain due to oral mucositis in patients receiving stem cell transplantation.
Topics: Adolescent; Adult; Aged; Analgesics, Opioid; Female; Fentanyl; Humans; Leukemia; Lymphoma, Non-Hodgk | 2005 |